Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4902271 | 0.97 | MGLL (0.33) | MGLLMAPK1MAPTRECQLALDH1A1 | |
| SCHEMBL4908861 | 0.94 | — | — | |
| SCHEMBL22712661 | 0.90 | MGLL (0.37) | MGLLMAPK1MAPTDGKAKMT2A | |
| SCHEMBL28342168 | 0.88 | DGKA (0.40) | MGLLDGKAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL28192296 | 0.88 | DGKA (0.40) | MGLLDGKAALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL310052 | 0.87 | MGLL (0.37) | MGLLMAPK1MAPTDGKARECQL | |
| SCHEMBL28353477 | 0.87 | SMN1; SMN2 (0.38) | ALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL30393585 | 0.85 | SMN1; SMN2 (0.37) | ALDH1A1KMT2ASMN1; SMN2 | |
| Ethylene Glycol SCHEMBL4893242 | 0.84 | KMT2A (0.37) | KMT2ASMN1; SMN2 | |
| SCHEMBL1869815 | 0.84 | ADRA2A (0.33) | MGLLMAPTALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | claimed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | claimed |
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | SUNBIO, INC. (KR) | 2008-07-03 | — | — | US | disclosed |
| EP-1938795-A2 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | Sunbio, Inc. (KR) | 2008-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080159975-A1 | Hair treatment composition, hair treatment agent and method for treating hair by using the same | KRT18, CUTA, KRTCAP2 | MGLL 1682/4885MAPK1 3218/4885MAPT 470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.